- Tytuł:
- Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study
- Autorzy:
- Źródło:
- In The Lancet Oncology January 2024 25(1):29-45
Czasopismo naukowe